GVCAX | VMVAX | GVCAX / VMVAX | |
Total Expense Ratio | 1.45 | 0.07 | 2,071% |
Annual Report Gross Expense Ratio | 1.45 | 0.07 | 2,071% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 20.994 | 6.339 | 331% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 230M | 32.5B | 1% |
Annual Yield % from dividends | 0.45 | 2.17 | 21% |
Returns for 1 year | 8.95 | 1.20 | 744% |
Returns for 3 years | 11.16 | 36.10 | 31% |
Returns for 5 years | -2.36 | 63.10 | -4% |
Returns for 10 years | -28.58 | 99.51 | -29% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LMLSX | 42.07 | 0.28 | +0.67% |
ClearBridge Large Cap Value IS | |||
ACSRX | 31.54 | 0.17 | +0.54% |
Invesco Comstock R | |||
CRRYX | 15.28 | 0.01 | +0.07% |
Columbia Sm Cp Val and Inflection Inst3 | |||
PZISX | 13.25 | N/A | N/A |
Pzena Small Cap Value Institutional | |||
MOINX | 25.41 | -0.06 | -0.24% |
NYLI WMC Small Companies Investor Class |